GW
OMGA

GW & Wade’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

GW & Wade’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$30K Hold
10,000
– – ﹤0.01% 406
2023
Q3 		$22K Hold
10,000
– – ﹤0.01% 399
2023
Q2 		$56K Hold
10,000
– – ﹤0.01% 381
2023
Q1 		$60K Hold
10,000
– – ﹤0.01% 372
2022
Q4 		$57K Hold
10,000
– – ﹤0.01% 381
2022
Q3 		$54K Hold
10,000
– – ﹤0.01% 375
2022
Q2 		$38K Buy
+10,000
New +$37.2K ﹤0.01% 379

Other funds holding OMGA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

GW & Wade's OMGA Position: Q4 2023 in Review

GW & Wade held its Omega Therapeutics, Inc. Common Stock (OMGA) position steady in Q4 2023 at 10,000 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #406.

GW & Wade first reported a position in OMGA in Q2 2022 and has held it in 7 quarters since. The position peaked at $60K in Q1 2023. 63 funds tracked by Wall St. Rank hold OMGA as of Q4 2023.

  • GW & Wade held 10,000 shares of Omega Therapeutics, Inc. Common Stock worth $30K as of Q4 2023.
  • GW & Wade left its Omega Therapeutics, Inc. Common Stock share count unchanged in Q4 2023.
  • Omega Therapeutics, Inc. Common Stock made up ﹤0.01% of GW & Wade's portfolio in Q4 2023, its #406 holding.
  • GW & Wade first reported a position in Omega Therapeutics, Inc. Common Stock in Q2 2022 and has held it in 7 quarters since.
  • GW & Wade's Omega Therapeutics, Inc. Common Stock position peaked at $60K in Q1 2023.
  • 63 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q4 2023.

Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.